var data={"title":"IgG subclass deficiency","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">IgG subclass deficiency</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/contributors\" class=\"contributor contributor_credentials\">Alan P Knutsen, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/contributors\" class=\"contributor contributor_credentials\">E Richard Stiehm, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/contributors\" class=\"contributor contributor_credentials\">Anna M Feldweg, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical presentation, pathogenesis, diagnosis, and treatment of immunoglobulin G (IgG) subclass deficiency are presented here. The physical and biologic properties of IgG subclasses are reviewed separately. (See <a href=\"topic.htm?path=igg-subclasses-physical-properties-genetics-and-biologic-functions\" class=\"medical medical_review\">&quot;IgG subclasses: Physical properties, genetics, and biologic functions&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3539609208\"><span class=\"h1\">DEFINITIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The term &quot;IgG subclass deficiency&quot; refers to a significant decrease in the serum concentrations of one or more subclasses of IgG in a patient <strong>whose total IgG concentration is normal</strong> [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/1\" class=\"abstract_t\">1</a>].</p><p class=\"headingAnchor\" id=\"H1598063723\"><span class=\"h2\">Clinically significant deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IgG subclass deficiency is a laboratory finding that does not necessarily equate to a clinical disorder. The diagnosis of a <strong>clinically significant</strong> IgG subclass deficiency requires evidence of antibody dysfunction in the form of recurrent infections and an inadequate response to vaccine challenge.</p><p class=\"headingAnchor\" id=\"H1302737383\"><span class=\"h2\">Lower limits of normal</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The normal ranges for IgG subclasses are broad and vary with the age of the population studied, presence or absence of disease, and the method of analysis (<a href=\"image.htm?imageKey=ALLRG%2F50967\" class=\"graphic graphic_table graphicRef50967 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/2-9\" class=\"abstract_t\">2-9</a>].</p><p>For children 4 to 10 years of age, levels below the following are considered abnormal:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG1 level &lt;250 <span class=\"nowrap\">mg/dL</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG2 level &lt;50 <span class=\"nowrap\">mg/dL</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG3 level &lt;15 <span class=\"nowrap\">mg/dL</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG4 level &lt;1 <span class=\"nowrap\">mg/dL</span></p><p/><p class=\"bulletIndent1\">For individuals older than 10 years of age, levels below the following are considered abnormal:</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG1 level &lt;300 <span class=\"nowrap\">mg/dL</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG2 level &lt;50 <span class=\"nowrap\">mg/dL</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG3 level &lt;25 <span class=\"nowrap\">mg/dL</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG level &lt;1 <span class=\"nowrap\">mg/dL</span></p><p/><p>In one study, up to 20 percent of an unselected population had levels of one or more of the IgG subclasses below these lower limits of normal, a finding that has fueled ongoing debate about whether or not IgG subclass deficiency truly represents a primary immunodeficiency (<a href=\"image.htm?imageKey=ALLRG%2F66552\" class=\"graphic graphic_table graphicRef66552 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/10,11\" class=\"abstract_t\">10,11</a>].</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Among patient populations with more frequent or severe infections, IgG subclass deficiency is a common finding:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In two large series from France, IgG subclass deficiency was detected in 21 percent of 483 patients with abnormally frequent, prolonged, or severe infections who had been recruited from clinical immunology, pediatrics, and infectious diseases departments [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/5,9\" class=\"abstract_t\">5,9</a>]. IgG3 was the most frequently deficient subclass, which has also been observed in other studies [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/2-4,12\" class=\"abstract_t\">2-4,12</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a report of 1175 adults with symptoms suggestive of an antibody defect, decreased IgG1, IgG2, IgG3, and IgG4 levels were noted in 28, 17, 13, and 9 percent, respectively (<a href=\"image.htm?imageKey=ALLRG%2F66552\" class=\"graphic graphic_table graphicRef66552 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/11\" class=\"abstract_t\">11</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The sex distribution of IgG subclass deficiency differs in children and adults. In children, IgG subclass deficiencies are more common in boys by a ratio of 3:1 [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/2,3\" class=\"abstract_t\">2,3</a>]. In contrast, there is a predominance of females after age 16. This shift in sex distribution may be due to hormonal influences upon the development and maturation of the immune system.</p><p/><p class=\"headingAnchor\" id=\"H99694778\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The primary mechanisms underlying IgG subclass deficiency are unclear. Gene deletions, transcription errors, cytokine dysregulation, immunosuppressive therapy, and allotypic variations are some mechanisms that have been described:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Gene deletions</strong> &ndash; Heterozygous gene deletions result in reduced serum levels of the corresponding subclass. Deletions have been described for genes C-gamma-1, C-gamma-2, and C-gamma-4 [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/13\" class=\"abstract_t\">13</a>]. Rare homozygous gene deletions, resulting in the complete absence of a subclass, have been reported [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/14\" class=\"abstract_t\">14</a>]. Homozygous deletions of large portions of the immunoglobulin heavy chain gene, resulting in the absence of multiple immunoglobulin classes, are also described. Such patients may have no detectable IgG1, IgG2, IgG4, IgA1, or IgE [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/15,16\" class=\"abstract_t\">15,16</a>]. Such deletions are thought to arise from unequal crossover, resulting from extensive homology among the immunoglobulin heavy chain genes on chromosome 14.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Transcription errors</strong> &ndash; The mechanism of germline transcription may be negatively altered in a significant number of patients with IgG4 subclass deficiency. Restriction fragment length polymorphisms 5' of the S-gamma-4 loci within the gamma-chain constant region gene complex have been specifically documented in patients with IgG4 deficiency patients compared with controls [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/17\" class=\"abstract_t\">17</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Effect of allotype</strong> &ndash; Some IgG subclass deficiencies appear to be influenced by allotype. A lack of the G2m(n) allotype was demonstrated in both IgG2-deficient and IgG3-deficient Caucasian patients, and homozygosity for the G3m(g) and G3m(b) allotypes was found in IgG3-deficient patients [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/18,19\" class=\"abstract_t\">18,19</a>]. The genes that encode the IgG subclasses, as well as the influence of allotype on subclass levels and allotype nomenclature, are discussed separately. (See <a href=\"topic.htm?path=igg-subclasses-physical-properties-genetics-and-biologic-functions#H3\" class=\"medical medical_review\">&quot;IgG subclasses: Physical properties, genetics, and biologic functions&quot;, section on 'Genetics'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IgG subclass deficiency may be asymptomatic or associated with recurrent infections and a heterogeneous group of related disorders. Interpretation of the available medical literature is complicated by the fact that many series have considered both asymptomatic and symptomatic patients together. Early studies (beginning in the 1970s) of patients with recurrent infections did not routinely assess antibody function [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/20\" class=\"abstract_t\">20</a>].</p><p class=\"headingAnchor\" id=\"H6410636\"><span class=\"h2\">Asymptomatic</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most individuals lacking one or more IgG subclass are asymptomatic [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/21-28\" class=\"abstract_t\">21-28</a>]. In addition, there are patients with complete deficiencies of multiple subclasses (combinations of IgG1, IgG2, IgG4, IgE, or IgA) who remain healthy and free of infections [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/29-32\" class=\"abstract_t\">29-32</a>].</p><p class=\"headingAnchor\" id=\"H2849742500\"><span class=\"h2\">Symptomatic</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with symptomatic IgG subclass deficiency most commonly present with recurrent sinopulmonary infections. The infections vary in frequency and severity and include otitis media, sinusitis, and pneumonia, which are usually due to common respiratory bacterial pathogens [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/1,25,26,33,34\" class=\"abstract_t\">1,25,26,33,34</a>]. More serious infections that can occur include osteomyelitis, meningitis, septicemia, diarrhea, and various skin infections [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H2038392682\"><span class=\"h3\">Associated disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IgG subclass deficiencies are associated with other primary immunodeficiencies, atopic disorders, chronic airway diseases, and autoimmunity.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG subclass deficiencies are most strongly associated with IgA deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/35\" class=\"abstract_t\">35</a>]. Approximately 15 percent of IgA-deficient patients also have IgG subclass deficiency, such as IgA, IgG2, and IgG4 deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/36,37\" class=\"abstract_t\">36,37</a>]. Associations have also been reported between IgG subclass deficiency and ataxia-telangiectasia [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/38\" class=\"abstract_t\">38</a>], as well as selective IgM deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/39\" class=\"abstract_t\">39</a>]. (See <a href=\"topic.htm?path=selective-iga-deficiency-clinical-manifestations-pathophysiology-and-diagnosis\" class=\"medical medical_review\">&quot;Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis&quot;</a> and <a href=\"topic.htm?path=ataxia-telangiectasia\" class=\"medical medical_review\">&quot;Ataxia-telangiectasia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Atopic disease is more common in patients with IgG subclass deficiency, compared with the general population [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/2,40,41\" class=\"abstract_t\">2,40,41</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic airway diseases, particularly asthma and chronic obstructive pulmonary disease, are found with a high frequency among patients with IgG subclass deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/2,40,42\" class=\"abstract_t\">2,40,42</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autoimmune conditions, such as vasculitis and cytopenias, are more common in patients with IgG subclass deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/43,44\" class=\"abstract_t\">43,44</a>].</p><p/><p class=\"headingAnchor\" id=\"H4139201961\"><span class=\"h3\">Specific deficiencies</span></p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h4\">IgG1 deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most patients with IgG1 deficiency have generalized hypogammaglobulinemia, since IgG1 normally comprises almost two-thirds of the total serum IgG (<a href=\"image.htm?imageKey=ALLRG%2F110543\" class=\"graphic graphic_table graphicRef110543 \">table 3</a>). Thus, most patients with significant IgG1 deficiency are classified as common variable immunodeficiency (CVID), a diagnosis that also requires decreased levels of IgA <span class=\"nowrap\">and/or</span> IgM. Only patients with selective IgG1 deficiency and normal levels of total IgG should be diagnosed with IgG1 deficiency. (See <a href=\"topic.htm?path=igg-subclasses-physical-properties-genetics-and-biologic-functions\" class=\"medical medical_review\">&quot;IgG subclasses: Physical properties, genetics, and biologic functions&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-epidemiology-and-diagnosis-of-common-variable-immunodeficiency-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults&quot;</a>.)</p><p>Selective IgG1 deficiency with normal total IgG is uncommon. In a large study, selective IgG1 deficiency was detected in 119 of 3005 patients (4 percent) with frequent <span class=\"nowrap\">and/or</span> repeated infections [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/45\" class=\"abstract_t\">45</a>]. These patients, predominately adults, had low IgG1 levels with normal levels of the other IgG subclasses, IgM, and IgA, thus excluding the diagnosis of CVID. Approximately 80 percent suffered from recurrent, predominately sinopulmonary infections, and 20 percent had asthma. In children &lt;5 years old, IgG1 deficiency may be transient hypogammaglobulinemia of infancy. (See <a href=\"topic.htm?path=transient-hypogammaglobulinemia-of-infancy\" class=\"medical medical_review\">&quot;Transient hypogammaglobulinemia of infancy&quot;</a>.)</p><p>IgG1 deficiency occasionally occurs with concomitant elevations in IgA or IgM or in combination with IgG3 deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/11,20\" class=\"abstract_t\">11,20</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h4\">IgG2 deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IgG2 subclass deficiency is more prevalent among children than adults and is one of the most frequently identified disorders in children with recurrent infections [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/3,46\" class=\"abstract_t\">3,46</a>]. It has been described both as an isolated finding and in combination with IgG4 <span class=\"nowrap\">and/or</span> IgA deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/36,47\" class=\"abstract_t\">36,47</a>].</p><p>IgG2 is predominantly responsible for the antibody response against polysaccharide capsular antigens. As a result, IgG2-deficient patients are at increased risk for infections with <em>Streptococcus pneumoniae</em>, <em>Haemophilus influenzae</em> type b (Hib), and <em>Neisseria meningitidis</em> [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/48-51\" class=\"abstract_t\">48-51</a>]. Sinopulmonary infections, including sinusitis, otitis media, and bronchitis predominate. However, more severe infections may also occur, such as pneumonia and meningococcemia [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/50,51\" class=\"abstract_t\">50,51</a>]. Obstructive lung disease and bronchiectasis have been reported with longstanding disease [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/52\" class=\"abstract_t\">52</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bronchiectasis-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of bronchiectasis in adults&quot;</a>.)</p><p>Compared with adults, healthy children have lower levels of IgG2. In addition, IgG2 levels rise to adult levels more slowly than do other subclasses (<a href=\"image.htm?imageKey=ALLRG%2F58666\" class=\"graphic graphic_figure graphicRef58666 \">figure 1</a>). IgG2 levels are 20 percent of adult levels at 1 year of age, 50 percent at 5 years of age, and 75 percent at 14 years of age. By comparison, IgG1 and IgG3 levels rise more rapidly and reach about 50 percent of adult levels by 1 year of age and 75 percent by 5 years of age.</p><p>IgG2 subclass deficiency has been reported in association with a variety of disorders:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autoimmune disorders, including systemic lupus erythematosus, juvenile diabetes mellitus, primary Sj&ouml;gren syndrome, autoimmune cytopenias, and vasculitides, such as immunoglobulin A vasculitis (IgAV; Henoch-Sch&ouml;nlein purpura [HSP]) [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/43,53-55\" class=\"abstract_t\">43,53-55</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other primary immunodeficiencies, including ataxia-telangiectasia, defects in the production of interferon-gamma (IFN-gamma), and chronic mucocutaneous candidiasis [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/38,56,57\" class=\"abstract_t\">38,56,57</a>]. In children, an association has been reported among specific antibody deficiency, IgG2 subclass deficiency, and mannose-binding lectin deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/58\" class=\"abstract_t\">58</a>]. (See <a href=\"topic.htm?path=inherited-disorders-of-the-complement-system\" class=\"medical medical_review\">&quot;Inherited disorders of the complement system&quot;</a> and <a href=\"topic.htm?path=mannose-binding-lectin-deficiency\" class=\"medical medical_review\">&quot;Mannose-binding lectin deficiency&quot;</a> and <a href=\"topic.htm?path=ataxia-telangiectasia\" class=\"medical medical_review\">&quot;Ataxia-telangiectasia&quot;</a> and <a href=\"topic.htm?path=chronic-mucocutaneous-candidiasis\" class=\"medical medical_review\">&quot;Chronic mucocutaneous candidiasis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Secondary immunodeficiency states, such as human immunodeficiency virus infection and allogeneic bone marrow transplantation [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/59,60\" class=\"abstract_t\">59,60</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Several other disorders, including cystic fibrosis, severe H1N1 influenza, growth hormone deficiency, febrile seizures, Hodgkin lymphoma, and allergic colitis [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/61-68\" class=\"abstract_t\">61-68</a>].</p><p/><p>Data on the natural history of IgG2 subclass deficiency are limited:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The course of IgG2 deficiency was evaluated in a retrospective analysis of 120 children &ge;2 years old with recurrent infections and failure to respond to a majority of serotypes after <em>S.</em> <em>pneumoniae</em> immunization with the polysaccharide vaccine [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/41\" class=\"abstract_t\">41</a>]. IgG2, IgA, and IgA-IgG2 deficiency were identified in 19, 11, and 3 percent, respectively [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/41\" class=\"abstract_t\">41</a>]. After three years, immunoglobulin concentrations and polysaccharide responses had normalized in 87 percent.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In another series of 49 children with IgG subclass deficiency, of whom 76 percent had IgG2 deficiency, greater morbidity was observed [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/69\" class=\"abstract_t\">69</a>]. Ten percent of these children had bronchiectasis. On follow-up, 46 percent of the patients showed progressive immunodeficiency. Progression to CVID has been described in other case reports [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/70\" class=\"abstract_t\">70</a>].</p><p/><p class=\"headingAnchor\" id=\"H8\"><span class=\"h4\">IgG3 deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IgG3 subclass deficiency is more common in adults than children [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/3\" class=\"abstract_t\">3</a>]. It may occur alone or in combination with other subclass deficiencies, especially IgG1 [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/18,71\" class=\"abstract_t\">18,71</a>]. IgG3 is responsible for the immune response against <em>Moraxella catarrhalis</em> and to the M component of <em>S. pyogenes</em>, and these organisms are frequently implicated in infections in IgG3-deficient patients [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/40\" class=\"abstract_t\">40</a>].</p><p>Clinically, patients with symptomatic IgG3 deficiency commonly suffer from the same types of recurrent sinopulmonary infections as those with other subclass deficiencies. Antibody responses to polysaccharide antigens may be normal or impaired [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/4,26,72\" class=\"abstract_t\">4,26,72</a>]. In a series of 121 adult patients who suffered from severe recurrent bacterial lung infections and had isolated low IgG3 levels, response to <a href=\"topic.htm?path=pneumococcal-polysaccharide-vaccine-23-valent-drug-information\" class=\"drug drug_general\">pneumococcal polysaccharide vaccine</a> (eg, Pneumovax) was impaired in 34 percent [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/73\" class=\"abstract_t\">73</a>].</p><p>Asthma, chronic bronchitis, gastrointestinal infections, and recurrent lymphocytic meningitis have also been reported in patients with IgG3 deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/4,5,26,72,74\" class=\"abstract_t\">4,5,26,72,74</a>]. Case reports note associations with diabetes mellitus type 1, IgAV (HSP), recurrent herpes simplex infection, recurrent erysipelas, and complement component 2 (C2) deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/4,71\" class=\"abstract_t\">4,71</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h4\">IgG4 deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IgG4 deficiency is believed to be common in the general population, and the majority of affected people are asymptomatic [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/10\" class=\"abstract_t\">10</a>]. IgG4 subclass deficiency has been described alone, in combination with IgG2 deficiency, and with IgA-IgG2 deficiencies [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/22,36,75\" class=\"abstract_t\">22,36,75</a>]. Recurrent pulmonary infections and bronchiectasis are reported in symptomatic patients [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/28,75-77\" class=\"abstract_t\">28,75-77</a>].</p><p>IgG4 deficiency has been reported in association with various other disorders, including ataxia-telangiectasia, chronic mucocutaneous candidiasis, growth hormone deficiency, allergic colitis, and Down syndrome [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/57,60,65,66,71,78\" class=\"abstract_t\">57,60,65,66,71,78</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with IgG subclass deficiency most commonly present with recurrent sinopulmonary infections. An initial approach to patients with recurrent infections, including key aspects of the clinical history and physical exam, is reviewed in detail elsewhere:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=approach-to-the-child-with-recurrent-infections\" class=\"medical medical_review\">&quot;Approach to the child with recurrent infections&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=approach-to-the-adult-with-recurrent-infections\" class=\"medical medical_review\">&quot;Approach to the adult with recurrent infections&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2631432465\"><span class=\"h2\">Initial laboratories</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The initial laboratory evaluation should include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A complete blood count and differential</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Total serum IgG, IgA, IgM, and IgE levels</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG subclasses (some investigators obtain IgG subclasses at the initial evaluation, whereas others measure them only if vaccine response is impaired)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antibody titers to proteins and polysaccharide antigens, such as diphtheria toxoid, tetanus toxoid, <em>H</em>. <em>influenzae</em> type B (Hib), and <em>S</em>. <em>pneumoniae</em></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Total hemolytic complement (CH50) and alternative hemolytic complement (AH50)</p><p/><p>If the results of any of these laboratories are abnormal, then a problem with that component of the immune system should be pursued first. (See <a href=\"topic.htm?path=laboratory-evaluation-of-the-immune-system\" class=\"medical medical_review\">&quot;Laboratory evaluation of the immune system&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3974236503\"><span class=\"h2\">Referral and further evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Referral to an immunology specialist is indicated, if possible, for patients with recurrent sinopulmonary infections and either normal or abnormal results to the initial screening laboratory tests mentioned above. (See <a href=\"#H2631432465\" class=\"local\">'Initial laboratories'</a> above.)</p><p>Further evaluation involves:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Assessment of the patient's responses to past infections and vaccination</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Measurement of IgG subclass levels (if not done earlier)</p><p/><p class=\"headingAnchor\" id=\"H3248284418\"><span class=\"h3\">Assess antibody function</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The function of the patient's IgG antibodies can be assessed by measuring antibody titers to previously administered vaccines or natural infections. If titers are not in the protective range, a vaccine challenge is performed, which refers to the administration of vaccines with measurement of pre- and postimmunization titers. Vaccine challenge serves as a correlate of the patient's ability to respond effectively to natural infections and is a means of determining the clinical significance of an IgG subclass deficiency. Lack of response, especially to <em>S</em>. <em>pneumoniae</em> and <em>H</em>. <em>influenzae</em> vaccines, correlates with clinical susceptibility to recurrent sinopulmonary infections [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/6,20,26,33,36,41,47,48\" class=\"abstract_t\">6,20,26,33,36,41,47,48</a>].</p><p>A detailed discussion of how to assess antibody function and interpret vaccine responses is found elsewhere. (See <a href=\"topic.htm?path=assessing-the-immunologic-response-to-vaccination\" class=\"medical medical_review\">&quot;Assessing the immunologic response to vaccination&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H263812276\"><span class=\"h4\">Children under two years of age</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Immune response to polysaccharide antigens can be assessed in children &lt;2 years old by measuring <em>S</em>. <em>pneumoniae</em> serotype antibody responses after immunization with the conjugated pneumococcal vaccine (Prevnar) and measuring <em>H</em>. <em>influenzae</em> type B antibody titer in response to conjugated <em>H</em>. <em>influenzae</em> vaccination. It is the author's experience that young children who respond poorly to full immunization with conjugated pneumococcal vaccines often subsequently respond poorly to polysaccharide vaccines when they are older. As a result, the measurement of anti-pneumococcal and anti-<em>Haemophilus</em> antibodies in children who have received conjugated vaccines for these pathogens is informative. These tests are commercially available, usually in panels of 13 to 23 serotypes. (See <a href=\"topic.htm?path=assessing-the-immunologic-response-to-vaccination\" class=\"medical medical_review\">&quot;Assessing the immunologic response to vaccination&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3455040458\"><span class=\"h4\">Response patterns seen with IgG subclass deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vaccine responses of patients with IgG subclass deficiencies are characterized by the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with IgG1 subclass deficiency usually have hypogammaglobulinemia and are diagnosed with other disorders. (See <a href=\"topic.htm?path=clinical-manifestations-epidemiology-and-diagnosis-of-common-variable-immunodeficiency-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults&quot;</a> and <a href=\"topic.htm?path=transient-hypogammaglobulinemia-of-infancy\" class=\"medical medical_review\">&quot;Transient hypogammaglobulinemia of infancy&quot;</a> and <a href=\"topic.htm?path=primary-humoral-immunodeficiencies-an-overview\" class=\"medical medical_review\">&quot;Primary humoral immunodeficiencies: An overview&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with IgG2 subclass deficiency (possibly in combination with selective IgA <span class=\"nowrap\">and/or</span> IgG4 deficiency) may have defective polysaccharide vaccine responses with some regularity. By comparison, such patients typically have normal baseline immunity to protein antigens and respond normally to protein vaccines.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with IgG4 deficiency typically produce normal antibody responses to both protein and polysaccharide antigens.</p><p/><p class=\"headingAnchor\" id=\"H146322460\"><span class=\"h3\">IgG subclass levels</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following are important points about the measurement of IgG subclasses:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low IgG subclass concentrations should be confirmed on at least one other occasion, two to four weeks after the first measurement [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/79,80\" class=\"abstract_t\">79,80</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IgG subclass levels change rapidly from birth to two years of age (<a href=\"image.htm?imageKey=ALLRG%2F58666\" class=\"graphic graphic_figure graphicRef58666 \">figure 1</a>).</p><p/><p>Different methods are used for the quantitative determination of IgG subclasses, which include enzyme-linked immunosorbent assay, radial immunodiffusion, nephelometry, and radioimmune assay. IgG subclass standard sera is calibrated against IgG subclass levels in World Health Organization reference serum <span class=\"nowrap\">67/97</span>.</p><p class=\"headingAnchor\" id=\"H1701610\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of a <strong>clinically significant</strong> IgG subclass deficiency requires all three of the below components [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/81\" class=\"abstract_t\">81</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The clinical history of recurrent sinopulmonary infections.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The laboratory finding of deficiency of one or more IgG subclasses, typically to levels less than 2 standard deviations below the age-specific mean, in the presence of normal or near-normal total serum IgG concentrations. (See <a href=\"#H1302737383\" class=\"local\">'Lower limits of normal'</a> above.)</p><p/><p class=\"bulletIndent1\">These levels should be assessed on at least two occasions while the patient is free of acute infections, using methods that are capable of detecting values in the very low ranges (ie, 1 to 8 <span class=\"nowrap\">mg/dL),</span> such as enzyme-linked immunosorbent assays.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The demonstration of an inadequate antibody response, typically to polysaccharide vaccine challenge. Vaccine challenge is reviewed in detail separately. (See <a href=\"topic.htm?path=assessing-the-immunologic-response-to-vaccination\" class=\"medical medical_review\">&quot;Assessing the immunologic response to vaccination&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H19\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Other conditions must be considered in patients with clinical features suggestive of IgG subclass deficiency but lacking either of the two criteria for the diagnosis (ie, low IgG subclass levels or poor antibody response to vaccine challenge).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Functionally normal</strong> &ndash; Patients with low IgG subclass levels but normal immune responses to vaccination may be immunologically normal. Many such patients have been described. This combination of findings in a child may represent the evolution of transient hypogammaglobulinemia of infancy. (See <a href=\"topic.htm?path=transient-hypogammaglobulinemia-of-infancy\" class=\"medical medical_review\">&quot;Transient hypogammaglobulinemia of infancy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Secondary immunodeficiency</strong> &ndash; Patients with IgG subclass deficiency, normal immune responses to vaccination, and recurrent sinopulmonary infections may have secondary hypogammaglobulinemia. Secondary hypogammaglobulinemia can result from either decreased production or increased loss.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Malignancy (chronic lymphocytic leukemia or lymphoma) can result in decreased immunoglobulin production [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/62\" class=\"abstract_t\">62</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Viral infections (eg, Epstein-Barr virus, human immunodeficiency virus, cytomegalovirus, and congenital rubella) and systemic illnesses causing bone marrow suppression are other secondary causes of hypogammaglobulinemia. (See <a href=\"topic.htm?path=secondary-immunodeficiency-due-to-underlying-disease-states-environmental-exposures-and-miscellaneous-causes#H23\" class=\"medical medical_review\">&quot;Secondary immunodeficiency due to underlying disease states, environmental exposures, and miscellaneous causes&quot;, section on 'Infections (other than HIV)'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Certain medications, including systemic glucocorticoids, <a href=\"topic.htm?path=sulfasalazine-drug-information\" class=\"drug drug_general\">sulfasalazine</a>, and the anti-epileptics <a href=\"topic.htm?path=zonisamide-drug-information\" class=\"drug drug_general\">zonisamide</a>, <a href=\"topic.htm?path=phenytoin-drug-information\" class=\"drug drug_general\">phenytoin</a>, and <a href=\"topic.htm?path=carbamazepine-drug-information\" class=\"drug drug_general\">carbamazepine</a>, have been associated with acquired cases of IgG subclass deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/82-86\" class=\"abstract_t\">82-86</a>]. (See <a href=\"topic.htm?path=primary-humoral-immunodeficiencies-an-overview#H87306119\" class=\"medical medical_review\">&quot;Primary humoral immunodeficiencies: An overview&quot;, section on 'Medications that cause hypogammaglobulinemia'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Abnormal loss of immunoglobulins can be observed in protein-losing enteropathies, nephrotic syndrome, burns, and other traumas. (See <a href=\"topic.htm?path=secondary-immunodeficiency-due-to-underlying-disease-states-environmental-exposures-and-miscellaneous-causes\" class=\"medical medical_review\">&quot;Secondary immunodeficiency due to underlying disease states, environmental exposures, and miscellaneous causes&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cigarette smoking has also been associated with lower IgG2 subclass levels [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/87\" class=\"abstract_t\">87</a>].</p><p/><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most patients with IgG subclass deficiencies do well with appropriate treatment and suffer significantly fewer sinopulmonary infections. Treatment of patients with IgG subclass deficiency includes the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immunization with conjugate vaccines in patients who have not responded to polysaccharide vaccines</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aggressive management of other conditions predisposing to recurrent sinopulmonary infections (eg, asthma, allergic rhinitis)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased vigilance and appropriate antibiotic therapy for infections</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prophylactic antibiotics</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intravenous or subcutaneous <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-drug-information\" class=\"drug drug_general\">immune globulin</a> replacement</p><p/><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Vaccination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>All patients with IgG subclass deficiency and poor responses to polysaccharide vaccines should receive a conjugated pneumococcal vaccine in order to boost immunity to this common respiratory pathogen. There are no data examining efficacy of these vaccines in patients with IgG subclass deficiency, although benefits have been observed in children with specific antibody deficiency (SAD). As an example, in one study of patients with vaccine nonresponse, the conjugated pneumococcal vaccine (Prevnar or a similar preparation) produced a protective response in 80 to 90 percent of patients &ge;2 years of age who failed to respond to the unconjugated polysaccharide vaccine [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/88\" class=\"abstract_t\">88</a>]. A similar response may occur in patients with subclass deficiency, as clinical improvement is often observed after this intervention. (See <a href=\"topic.htm?path=pneumococcal-streptococcus-pneumoniae-conjugate-vaccines-in-children#H3\" class=\"medical medical_review\">&quot;Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children&quot;, section on 'Conjugate vaccines'</a>.)</p><p>Updated recommendations for <em>H.</em> <em>influenzae</em> type B (Hib) immunization were published in 2014 by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) and included patients with antibody deficiency [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/89,90\" class=\"abstract_t\">89,90</a>]. The ACIP recommended that conjugated Hib vaccine be administered in patients with IgG2 subclass deficiency and those with SAD [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/89,90\" class=\"abstract_t\">89,90</a>]. (See <a href=\"topic.htm?path=prevention-of-haemophilus-influenzae-type-b-infection\" class=\"medical medical_review\">&quot;Prevention of Haemophilus influenzae type b infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1918323\"><span class=\"h2\">Treatment of infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Prompt recognition and treatment of sinopulmonary bacterial infections is a significant component of management of these patients, since infections are less likely to clear spontaneously in patients with antibody defects. When possible, infections should be verified through sinus and lung imaging, complete blood counts, and culture data. (See <a href=\"topic.htm?path=acute-bronchitis-in-adults\" class=\"medical medical_review\">&quot;Acute bronchitis in adults&quot;</a> and <a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-clinical-features-and-diagnosis#H9\" class=\"medical medical_review\">&quot;Acute bacterial rhinosinusitis in children: Clinical features and diagnosis&quot;, section on 'Acute bacterial rhinosinusitis'</a> and <a href=\"topic.htm?path=community-acquired-pneumonia-in-children-clinical-features-and-diagnosis#H3\" class=\"medical medical_review\">&quot;Community-acquired pneumonia in children: Clinical features and diagnosis&quot;, section on 'Clinical evaluation'</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Management of other sinopulmonary disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Aggressive management of any conditions predisposing to recurrent sinopulmonary infections (especially allergic rhinitis and asthma) is critical to improving the clinical outcome of patients with IgG subclass deficiency. Atopic disorders occurred in 55 to 58 percent of the children with SAD with or without IgG2-IgA deficiency in one report [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/41\" class=\"abstract_t\">41</a>].</p><p>Management of allergic rhinitis and asthma includes allergy evaluation and trigger avoidance, nasal and inhaled glucocorticoids, bronchodilators, and antihistamines. (See <a href=\"topic.htm?path=pharmacotherapy-of-allergic-rhinitis\" class=\"medical medical_review\">&quot;Pharmacotherapy of allergic rhinitis&quot;</a> and <a href=\"topic.htm?path=an-overview-of-asthma-management\" class=\"medical medical_review\">&quot;An overview of asthma management&quot;</a>.)</p><p>Patients with IgG subclass deficiencies appear to respond normally to allergen immunotherapy for allergic rhinitis and asthma and should receive this therapy when appropriate. (See <a href=\"topic.htm?path=subcutaneous-immunotherapy-for-allergic-disease-indications-and-efficacy\" class=\"medical medical_review\">&quot;Subcutaneous immunotherapy for allergic disease: Indications and efficacy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Prophylactic antibiotics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with recurrent sinopulmonary infections despite the previously described measures usually require prophylactic antibiotics. Evidence in support of this approach is largely derived from benefits observed in retrospective studies of children with this and similar antibody deficiencies.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>One of the largest studies examined 120 children aged 2 to 15 years of age [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/41\" class=\"abstract_t\">41</a>]. Seventy-two percent were successfully managed with prophylactic antibiotics. Those who did not respond subsequently required <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-drug-information\" class=\"drug drug_general\">immune globulin</a> replacement therapy.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In another series of 59 children, prophylactic antibiotics were administered if the patient had more than six upper respiratory tract infections (RTIs) in one year, with or without an immunostimulant bacterial lysate, and <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-drug-information\" class=\"drug drug_general\">immune globulin</a> was administered to those who failed to improve adequately [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/12,91\" class=\"abstract_t\">12,91</a>]. During the years the children were followed, 90 percent required one of these therapies, and 15 percent received immune globulin. In the treated group, the frequency of infections decreased from 13&plusmn;7 to 6&plusmn;4 per year [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/12\" class=\"abstract_t\">12</a>].</p><p/><p>In the author's clinic, approximately one-half of children require prophylactic antibiotics. The specific prophylactic antibiotic selected should cover the bacteria that most commonly cause sinopulmonary infections, such as <em>S. pneumoniae</em> (including penicillin-resistant strains), nontypable <em>H. influenzae</em>, and <em>M. catarrhalis</em>.</p><p>The choice of agent and dose should be based upon resistance patterns within a community. Specific regimens of antibiotic prophylaxis for children and adults are presented elsewhere. (See <a href=\"topic.htm?path=primary-immunodeficiency-overview-of-management#H3942620081\" class=\"medical medical_review\">&quot;Primary immunodeficiency: Overview of management&quot;, section on 'Prophylactic antimicrobial therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Immune globulin therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Judicious use of <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-drug-information\" class=\"drug drug_general\">immune globulin</a> therapy is appropriate if the use of prophylactic antibiotics does not result in fewer infections <span class=\"nowrap\">and/or</span> in patients with persistent and symptomatic chronic rhinosinusitis. This therapy should be reserved for patients with clearly impaired responses to protein <span class=\"nowrap\">and/or</span> polysaccharide antigens [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/92,93\" class=\"abstract_t\">92,93</a>]. Most of the patients requiring this intervention have impaired antibody responses to bacterial polysaccharide antigens with IgG2 <span class=\"nowrap\">+/-</span> IgG4 deficiency, although there are reported cases of benefit in IgG3 deficiency as well [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/70\" class=\"abstract_t\">70</a>]. Intravenous immune globulin therapy, at a standard dose range of 400 to 600 <span class=\"nowrap\">mg/kg,</span> can be infused every three to four weeks [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/94\" class=\"abstract_t\">94</a>]. Immune globulin can also be replaced subcutaneously at weekly intervals. (See <a href=\"topic.htm?path=immune-globulin-therapy-in-primary-immunodeficiency\" class=\"medical medical_review\">&quot;Immune globulin therapy in primary immunodeficiency&quot;</a>.)</p><p>Patients with selective IgG4 or IgG3 deficiency usually have normal antibody responses, although differing degrees of impaired specific antibody responses in patients with IgG3 deficiency have been noted [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/72,95,96\" class=\"abstract_t\">72,95,96</a>]. The role of <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-drug-information\" class=\"drug drug_general\">immune globulin</a> in these patients is not as clear. However, several studies have reported clinical improvement in patients with IgG3 deficiency as a result of this intervention [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/72,95,97,98\" class=\"abstract_t\">72,95,97,98</a>]. In the largest study, which included 33 patients with IgG3 deficiency, patients with more than four antibiotic-requiring RTIs per year were treated with immune globulin, and the number of infections before and during treatment was compared [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/98\" class=\"abstract_t\">98</a>]. Reduction in the number of RTIs was seen in 29 of 33 patients with IgG3 deficiency: 23 experienced a &ge;50 percent reduction and 6 had a reduction of &lt;50 percent.</p><p><a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-drug-information\" class=\"drug drug_general\">Immune globulin</a> therapy should be administered for one to two years initially, at which point the patient's status should be re-evaluated to determine if the number <span class=\"nowrap\">and/or</span> severity of infections have been reduced. Not all patients with IgG subclass deficiencies benefit from immune globulin replacement, and the therapy should be discontinued if not effective in that individual [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/98\" class=\"abstract_t\">98</a>]. (See <a href=\"#H27\" class=\"local\">'Monitoring'</a> below.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The prognosis of IgG subclass deficiency is influenced by the age of the patient as well as the degree of deficiency.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evidence suggests that the majority of children younger than six to eight years of age with clinically significant IgG subclass deficiency and diminished specific antibody responses will normalize both antibody responsiveness and IgG subclass level(s) [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/10,41\" class=\"abstract_t\">10,41</a>]. This appears to be particularly true for young children with IgG2 and IgA deficiency and impaired responses to polysaccharide antigens. In contrast, if the condition persists beyond the age of six years, it is likely to be permanent.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adults with clinically significant IgG subclass deficiency and diminished specific antibody responses will rarely achieve normalization of a deficient IgG subclass level [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/10\" class=\"abstract_t\">10</a>]. It is the author's experience that a subset of these patients progress to common variable immunodeficiency. Development of chronic pulmonary diseases, such as bronchiectasis, is also a risk for such patients, and they must be monitored closely [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=pulmonary-complications-of-primary-immunodeficiencies#H23102184\" class=\"medical medical_review\">&quot;Pulmonary complications of primary immunodeficiencies&quot;, section on 'Monitoring for pulmonary disease'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Spontaneous resolution is less likely to occur in cases of complete absence of an IgG subclass, regardless of age.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The risk of lymphoma in patients with IgG subclass deficiencies has not been evaluated.</p><p/><p class=\"headingAnchor\" id=\"H27\"><span class=\"h1\">MONITORING</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Monitoring is influenced by the patient's age and the severity of illness.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In affected younger children (up to six years of age), levels of immunoglobulins and IgG subclasses should be measured yearly. Vaccine response should be assessed again if levels normalize.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In symptomatic older children with persistent deficiency and in adults, we re-evaluate levels annually for several years. If the condition persists throughout this period, then reassessment can be less frequent [<a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/41,70,99\" class=\"abstract_t\">41,70,99</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In patients receiving <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-drug-information\" class=\"drug drug_general\">immune globulin</a> replacement therapy, treatment should periodically be held after one to two years for immunologic and clinical reassessment. When discontinuing immune globulin, it is advisable to do so during the spring months to minimize exposure to viral infections. We generally wait three or four months after discontinuation before performing immune testing. (See <a href=\"topic.htm?path=overview-of-intravenous-immune-globulin-ivig-therapy\" class=\"medical medical_review\">&quot;Overview of intravenous immune globulin (IVIG) therapy&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H4256380096\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-primary-immunodeficiencies\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Primary immunodeficiencies&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>&quot;IgG subclass deficiency&quot; refers to a significant decrease in the serum concentrations of one or more subclasses of immunoglobulin G (IgG) in a patient <strong>whose total IgG concentration is normal</strong>. It is a laboratory finding that does not necessarily equate to a clinical disorder. The diagnosis of a <strong>clinically significant</strong> IgG subclass deficiency requires evidence of antibody dysfunction in the form of recurrent infections and an inadequate response to vaccine challenge. (See <a href=\"#H3539609208\" class=\"local\">'Definitions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most patients with low levels of one or more IgG subclasses are asymptomatic. Those with symptomatic IgG subclass deficiencies typically suffer from repeated sinopulmonary infections. Osteomyelitis, meningitis, septicemia, diarrhea, and various skin infections are reported less often. (See <a href=\"#H5\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The different subclass deficiencies may have specific clinical characteristics. (See <a href=\"#H4139201961\" class=\"local\">'Specific deficiencies'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>IgG1 deficiency almost always presents as hypogammaglobulinemia, since IgG1 normally makes up about 70 percent of total IgG. Therefore, only those patients with IgG1 deficiency with normal total IgG should be diagnosed with selective IgG1 deficiency.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>IgG2 deficiency, which may occur in combination with IgG4 <span class=\"nowrap\">and/or</span> IgA deficiency, is more common in children. Infections with <em>Streptococcus pneumoniae</em>, <em>Haemophilus influenzae</em> type b, and <em>Neisseria meningitidis</em> are characteristic, since IgG2 comprises most of the antibody response against polysaccharide capsular antigens.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>IgG3 deficiency is more common in adults and may occur together with IgG1 deficiency. Infections with <em>Moraxella catarrhalis</em> and <em>Streptococcus pyogenes</em> are typical.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>IgG4 deficiency may or may not be associated with symptomatic sinopulmonary infections.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The initial evaluation of patients suspected of having an antibody defect involves complete blood count and differential; total hemolytic complement (CH50) and alternative hemolytic complement (AH50); total IgG, IgM, IgA levels; and antibody titers to protein and polysaccharide antigens. The diagnosis of IgG subclass deficiency should be considered in a patient whose initial laboratory tests are normal. In this situation, the patient's responses to past infections and vaccination are assessed, and IgG subclass levels are measured. (See <a href=\"#H11\" class=\"local\">'Evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of a clinically significant IgG subclass deficiency involves fulfilling the following components (see <a href=\"#H1701610\" class=\"local\">'Diagnosis'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The clinical history of recurrent sinopulmonary infections.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>One or more low IgG subclasses with normal total IgG.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Inadequate response to vaccination.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Management consists of immunization with conjugate vaccines in patients who have not responded to polysaccharide vaccines, aggressive treatment of other conditions predisposing to recurrent sinopulmonary infections (eg, asthma, allergic rhinitis), and increased vigilance and appropriate antibiotic therapy for infections. (See <a href=\"#H20\" class=\"local\">'Management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest the use of prophylactic antibiotics for patients with repeated sinopulmonary infections despite the above measures (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). The choice of agent and dose should be based upon resistance patterns within a community. (See <a href=\"#H23\" class=\"local\">'Prophylactic antibiotics'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-drug-information\" class=\"drug drug_general\">immune globulin</a> therapy for patients with clearly impaired protein <span class=\"nowrap\">and/or</span> polysaccharide vaccine responses, in whom the use of prophylactic antibiotics has not resulted in fewer infections (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). (See <a href=\"#H24\" class=\"local\">'Immune globulin therapy'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H3136827177\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge J Keith Lemmon, MD, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/1\" class=\"nounderline abstract_t\">Herrod HG. Clinical significance of IgG subclasses. Curr Opin Pediatr 1993; 5:696.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/2\" class=\"nounderline abstract_t\">Hanson LA, S&ouml;derstr&ouml;m R, Avanzini A, et al. Immunoglobulin subclass deficiency. Pediatr Infect Dis J 1988; 7:S17.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/3\" class=\"nounderline abstract_t\">S&ouml;derstr&ouml;m T, S&ouml;derstr&ouml;m R, Avanzini A, et al. Immunoglobulin G subclass deficiencies. Int Arch Allergy Appl Immunol 1987; 82:476.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/4\" class=\"nounderline abstract_t\">Oxelius VA, Hanson LA, Bj&ouml;rkander J, et al. IgG3 deficiency: common in obstructive lung disease. Hereditary in families with immunodeficiency and autoimmune disease. Monogr Allergy 1986; 20:106.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/5\" class=\"nounderline abstract_t\">Aucouturier P, Lacombe C, Bremard C, et al. Serum IgG subclass levels in patients with primary immunodeficiency syndromes or abnormal susceptibility to infections. Clin Immunol Immunopathol 1989; 51:22.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/6\" class=\"nounderline abstract_t\">Bj&ouml;rkander J, Bengtsson U, Oxelius VA, Hanson LA. Symptoms in patients with lowered levels of IgG subclasses, with or without IgA deficiency, and effects of immunoglobulin prophylaxis. Monogr Allergy 1986; 20:157.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/7\" class=\"nounderline abstract_t\">Migone N, Oliviero S, de Lange G, et al. Multiple gene deletions within the human immunoglobulin heavy-chain cluster. Proc Natl Acad Sci U S A 1984; 81:5811.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/8\" class=\"nounderline abstract_t\">Nahm MH, Macke K, Kwon OH, et al. Immunologic and clinical status of blood donors with subnormal levels of IgG2. J Allergy Clin Immunol 1990; 85:769.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/9\" class=\"nounderline abstract_t\">Aucouturier P, Mariault M, Lacombe C, Preud'homme JL. Frequency of selective IgG subclass deficiency: a reappraisal. Clin Immunol Immunopathol 1992; 63:289.</a></li><li class=\"breakAll\">Ochs HD, Stiehm ER, Winkelstein JA, et al. Antibody deficiencies. In: Immunologic disorders in infants and children, 5th ed, Ochs HD, Stiehm ER, Winkelstein JA (Eds), Elsevier, Philadelphia 2004.</li><li class=\"breakAll\">Meulenbroek AJ, Zeijlemaker WP. Human IgG subclasses: Useful diagnostic markers for immunocompetence, 2nd edition, CLB, Amsterdam, The Netherlands 2000.</li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/12\" class=\"nounderline abstract_t\">Karaca NE, Karadeniz C, Aksu G, Kutukculer N. Clinical and laboratory evaluation of periodically monitored Turkish children with IgG subclass deficiencies. Asian Pac J Allergy Immunol 2009; 27:43.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/13\" class=\"nounderline abstract_t\">Rabbani H, Kondo N, Smith CI, Hammarstr&ouml;m L. The influence of gene deletions and duplications within the IGHC locus on serum immunoglobulin subclass levels. Clin Immunol Immunopathol 1995; 76:S214.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/14\" class=\"nounderline abstract_t\">Pan Q, Hammarstr&ouml;m L. Molecular basis of IgG subclass deficiency. Immunol Rev 2000; 178:99.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/15\" class=\"nounderline abstract_t\">Plebani A, Carbonara AO, Bottaro A, et al. Gene deletion as a cause of associated deficiency of IgA1, IgG2, IgG4 and IgE. Immunodeficiency 1993; 4:245.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/16\" class=\"nounderline abstract_t\">Carbonara AO, Demarchi M. Ig isotypes deficiency caused by gene deletions. Monogr Allergy 1986; 20:13.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/17\" class=\"nounderline abstract_t\">Bottaro A, DeMarchi M, DeLange GG, et al. Human IGHC locus restriction fragment length polymorphisms in IgG4 deficiency: evidence for a structural IGHC defect. Eur J Immunol 1989; 19:2159.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/18\" class=\"nounderline abstract_t\">Oxelius VA. Serum IgG and IgG subclass contents in different Gm phenotypes. Scand J Immunol 1993; 37:149.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/19\" class=\"nounderline abstract_t\">Oxelius VA. Lack of the G2m(n) allotype in IgG subclass deficiency, in IgG2 deficiency together with lack of G1m(a) and G3m(g), and in IgG3 deficiency together with lack of G1m(f) and G3m(b). Scand J Immunol 1990; 31:243.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/20\" class=\"nounderline abstract_t\">Schur PH, Borel H, Gelfand EW, et al. Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med 1970; 283:631.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/21\" class=\"nounderline abstract_t\">Shackelford PG, Granoff DM, Madassery JV, et al. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res 1990; 27:16.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/22\" class=\"nounderline abstract_t\">Oxelius VA. Chronic infections in a family with hereditary deficiency of IgG2 and IgG4. Clin Exp Immunol 1974; 17:19.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/23\" class=\"nounderline abstract_t\">Lefranc MP, Lefranc G, Rabbitts TH. Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals. Nature 1982; 300:760.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/24\" class=\"nounderline abstract_t\">Hammarstr&ouml;m L, Smith CI. IgG2 deficiency in a healthy blood donor. Concomitant lack of IgG2, IgA and IgE immunoglobulins and specific anti-carbohydrate antibodies. Clin Exp Immunol 1983; 51:600.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/25\" class=\"nounderline abstract_t\">Morgan G, Levinsky RJ. Clinical significance of IgG subclass deficiency. Arch Dis Child 1988; 63:771.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/26\" class=\"nounderline abstract_t\">Umetsu DT, Ambrosino DM, Quinti I, et al. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985; 313:1247.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/27\" class=\"nounderline abstract_t\">Lawton AR. IgG subclass deficiency and the day-care generation. Pediatr Infect Dis J 1999; 18:462.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/28\" class=\"nounderline abstract_t\">Hill SL, Mitchell JL, Burnett D, Stockley RA. IgG subclasses in the serum and sputum from patients with bronchiectasis. Thorax 1998; 53:463.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/29\" class=\"nounderline abstract_t\">Lefranc MP, Hammarstr&ouml;m L, Smith CI, Lefranc G. Gene deletions in the human immunoglobulin heavy chain constant region locus: molecular and immunological analysis. Immunodefic Rev 1991; 2:265.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/30\" class=\"nounderline abstract_t\">Hammarstr&ouml;m L, Carbonara AO, DeMarchi M, et al. Generation of the antibody repertoire in individuals with multiple immunoglobulin heavy chain constant region gene deletions. Scand J Immunol 1987; 25:189.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/31\" class=\"nounderline abstract_t\">Plebani A, Ugazio AG, Meini A, et al. Extensive deletion of immunoglobulin heavy chain constant region genes in the absence of recurrent infections: when is IgG subclass deficiency clinically relevant? Clin Immunol Immunopathol 1993; 68:46.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/32\" class=\"nounderline abstract_t\">Depiero A, Kaminski DA, Halsey JF, et al. Immunologic compensation in a patient with a large IgH constant region deletion. J Allergy Clin Immunol 2001; 107:1051.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/33\" class=\"nounderline abstract_t\">Ambrosino DM, Umetsu DT, Siber GR, et al. Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels. J Allergy Clin Immunol 1988; 81:1175.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/34\" class=\"nounderline abstract_t\">Schwitzgu&eacute;bel AJ, Jandus P, Lacroix JS, et al. Immunoglobulin deficiency in patients with chronic rhinosinusitis: Systematic review of the literature and meta-analysis. J Allergy Clin Immunol 2015; 136:1523.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/35\" class=\"nounderline abstract_t\">Yount WJ, Seligmann M, Hong R, et al. Imbalances of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemia. J Clin Invest 1970; 49:1957.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/36\" class=\"nounderline abstract_t\">Oxelius VA, Laurell AB, Lindquist B, et al. IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. N Engl J Med 1981; 304:1476.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/37\" class=\"nounderline abstract_t\">Plebani A, Monafo V, Avanzini MA, et al. Relationship between IgA and IgG subclass deficiencies: a reappraisal. Monogr Allergy 1986; 20:171.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/38\" class=\"nounderline abstract_t\">Oxelius VA, Berkel AI, Hanson LA. IgG2 deficiency in ataxia-telangiectasia. N Engl J Med 1982; 306:515.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/39\" class=\"nounderline abstract_t\">Yel L, Ramanuja S, Gupta S. Clinical and immunological features in IgM deficiency. Int Arch Allergy Immunol 2009; 150:291.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/40\" class=\"nounderline abstract_t\">de Moraes Lui C, Oliveira LC, Diogo CL, et al. Immunoglobulin G subclass concentrations and infections in children and adolescents with severe asthma. Pediatr Allergy Immunol 2002; 13:195.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/41\" class=\"nounderline abstract_t\">Wolpert J, Knutsen AP. Natural history of selective antibody deficiency to bacterial polysaccharide antigens in children. Pediatr Asthma Allergy Immunol 1998; 12:183.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/42\" class=\"nounderline abstract_t\">Kim JH, Park S, Hwang YI, et al. Immunoglobulin G Subclass Deficiencies in Adult Patients with Chronic Airway Diseases. J Korean Med Sci 2016; 31:1560.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/43\" class=\"nounderline abstract_t\">Bussel J, Morell A, Skvaril F. IgG2 deficiency in autoimmune cytopenias. Monogr Allergy 1986; 20:116.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/44\" class=\"nounderline abstract_t\">Bremard-Oury C, Aucouturier P, Debr&eacute; M, et al. Immunoglobulin G subclasses in patients with immunodeficiencies. Monogr Allergy 1986; 20:75.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/45\" class=\"nounderline abstract_t\">Lacombe C, Aucouturier P, Preud'homme JL. Selective IgG1 deficiency. Clin Immunol Immunopathol 1997; 84:194.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/46\" class=\"nounderline abstract_t\">Javier FC 3rd, Moore CM, Sorensen RU. Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol 2000; 84:25.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/47\" class=\"nounderline abstract_t\">Braconier JH, Nilsson B, Oxelius VA, Karup-Pedersen F. Recurrent pneumococcal infections in a patient with lack of specific IgG and IgM pneumococcal antibodies and deficiency of serum IgA, IgG2 and IgG4. Scand J Infect Dis 1984; 16:407.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/48\" class=\"nounderline abstract_t\">Siber GR, Schur PH, Aisenberg AC, et al. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 1980; 303:178.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/49\" class=\"nounderline abstract_t\">Hammarstr&ouml;m L, Smith CI. IgG subclasses in bacterial infections. Monogr Allergy 1986; 19:122.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/50\" class=\"nounderline abstract_t\">Bass JL, Nuss R, Mehta KA, et al. Recurrent meningococcemia associated with IgG2-subclass deficiency. N Engl J Med 1983; 309:430.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/51\" class=\"nounderline abstract_t\">Escobar-P&eacute;rez X, Dorta-Contreras AJ, Interi&aacute;n-Morales MT, et al. IgG2 immunodeficiency: association to pediatric patients with bacterial meningoencephalitis. Arq Neuropsiquiatr 2000; 58:141.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/52\" class=\"nounderline abstract_t\">O'Keeffe S, Finnegan P. IgG subclass deficiency. Chest 1993; 104:1940.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/53\" class=\"nounderline abstract_t\">Oxelius VA. Immunoglobulin G (IgG) subclasses and human disease. Am J Med 1984; 76:7.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/54\" class=\"nounderline abstract_t\">Eriksson P, Almroth G, Denneberg T, Lindstr&ouml;m FD. IgG2 deficiency in primary Sj&ouml;gren's syndrome and hypergammaglobulinemic purpura. Clin Immunol Immunopathol 1994; 70:60.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/55\" class=\"nounderline abstract_t\">Jim&eacute;nez A, L&oacute;pez-Trascasa M, Font&aacute;n G. Incidence of selective IgG2 deficiency in patients with vasculitis. Clin Exp Immunol 1989; 78:149.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/56\" class=\"nounderline abstract_t\">Inoue R, Kondo N, Kobayashi Y, et al. IgG2 deficiency associated with defects in production of interferon-gamma; comparison with common variable immunodeficiency. Scand J Immunol 1995; 41:130.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/57\" class=\"nounderline abstract_t\">Kalfa VC, Roberts RL, Stiehm ER. The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency. Ann Allergy Asthma Immunol 2003; 90:259.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/58\" class=\"nounderline abstract_t\">Lotz DR, Knutsen AP. Concomitant selective antibody deficiency in pediatric patients with mannose-binding lectin deficiency. Pediatric Allergy, Immunology, and Pulmonology 2010; 23:265.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/59\" class=\"nounderline abstract_t\">Parkin JM, Helbert M, Hughes CL, Pinching AJ. Immunoglobulin G subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS. AIDS 1989; 3:37.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/60\" class=\"nounderline abstract_t\">Aucouturier P, Barra A, Intrator L, et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70:779.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/61\" class=\"nounderline abstract_t\">Chan JF, To KK, Tse H, et al. The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin Vaccine Immunol 2011; 18:305.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/62\" class=\"nounderline abstract_t\">Zenone T, Souquet PJ, Cunningham-Rundles C, Bernard JP. Hodgkin's disease associated with IgA and IgG subclass deficiency. J Intern Med 1996; 240:99.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/63\" class=\"nounderline abstract_t\">Garside JP, Kerrin DP, Brownlee KG, et al. Immunoglobulin and IgG subclass levels in a regional pediatric cystic fibrosis clinic. Pediatr Pulmonol 2005; 39:135.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/64\" class=\"nounderline abstract_t\">De Gracia J, Rodrigo MJ, Morell F, et al. IgG subclass deficiencies associated with bronchiectasis. Am J Respir Crit Care Med 1996; 153:650.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/65\" class=\"nounderline abstract_t\">Wilson NW, Daaboul J, Bastian JF. Association of autoimmunity with IgG2 and IgG4 subclass deficiency in a growth hormone-deficient child. J Clin Immunol 1990; 10:330.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/66\" class=\"nounderline abstract_t\">Ojuawo A, Milla PJ, Lindley KJ. Serum immunoglobulin and immunoglobulin G subclasses in children with allergic colitis. West Afr J Med 1998; 17:206.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/67\" class=\"nounderline abstract_t\">Caksen H, Oner AF, Arslan S, et al. Immunoglobulin subgroups in children with febrile seizures. Pediatr Int 2001; 43:58.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/68\" class=\"nounderline abstract_t\">Lenti C, Masserini C, Barlocco A, et al. IgG2 deficiency in children with febrile convulsions: a familial study. Ital J Neurol Sci 1993; 14:561.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/69\" class=\"nounderline abstract_t\">Schatorj&eacute; EJ, de Jong E, van Hout RW, et al. The Challenge of Immunoglobulin-G Subclass Deficiency and Specific Polysaccharide Antibody Deficiency--a Dutch Pediatric Cohort Study. J Clin Immunol 2016; 36:141.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/70\" class=\"nounderline abstract_t\">Knutsen AP, Becker BA. Evolution of IgG subclass deficiency into common variable immunodeficiency in a child with pulmonary interstitial glycogenosis. Pediatr Asthma Allergy Immunol 2009; 21:191.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/71\" class=\"nounderline abstract_t\">Oxelius VA. IgG subclass pattern in primary immunodeficiency disorders. Monogr Allergy 1986; 19:156.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/72\" class=\"nounderline abstract_t\">Abrahamian F, Agrawal S, Gupta S. Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy. Clin Exp Immunol 2010; 159:344.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/73\" class=\"nounderline abstract_t\">Barton JC, Bertoli LF, Barton JC, Acton RT. Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infections. Cell Immunol 2016; 299:50.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/74\" class=\"nounderline abstract_t\">Snowden JA, Milford-Ward A, Cookson LJ, McKendrick MW. Recurrent lymphocytic meningitis associated with hereditary isolated IgG subclass 3 deficiency. J Infect 1993; 27:285.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/75\" class=\"nounderline abstract_t\">Heiner DC, Myers A, Beck CS. Deficiency of IgG4: a disorder associated with frequent infections and bronchiectasis that may be familial. Clin Rev Allergy 1983; 1:259.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/76\" class=\"nounderline abstract_t\">Bartmann P, Kleihauer E. Undetectable IgG4 in immunoprecipitation: association with repeated infections in children? Eur J Pediatr 1988; 148:211.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/77\" class=\"nounderline abstract_t\">Moss RB, Carmack MA, Esrig S. Deficiency of IgG4 in children: association of isolated IgG4 deficiency with recurrent respiratory tract infection. J Pediatr 1992; 120:16.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/78\" class=\"nounderline abstract_t\">Anner&eacute;n G, Magnusson CG, Lilja G, Nordvall SL. Abnormal serum IgG subclass pattern in children with Down's syndrome. Arch Dis Child 1992; 67:628.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/79\" class=\"nounderline abstract_t\">Hamilton RG. Human IgG subclass measurements in the clinical laboratory. Clin Chem 1987; 33:1707.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/80\" class=\"nounderline abstract_t\">Bossuyt X, Mari&euml;n G, Meyts I, et al. Determination of IgG subclasses: a need for standardization. J Allergy Clin Immunol 2005; 115:872.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/81\" class=\"nounderline abstract_t\">Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 2015; 136:1186.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/82\" class=\"nounderline abstract_t\">Klaustermeyer WB, Gianos ME, Kurohara ML, et al. IgG subclass deficiency associated with corticosteroids in obstructive lung disease. Chest 1992; 102:1137.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/83\" class=\"nounderline abstract_t\">Leickly FE, Buckley RH. Development of IgA and IgG2 subclass deficiency after sulfasalazine therapy. J Pediatr 1986; 108:481.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/84\" class=\"nounderline abstract_t\">Maeoka Y, Hara T, Dejima S, Takeshita K. IgA and IgG2 deficiency associated with zonisamide therapy: a case report. Epilepsia 1997; 38:611.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/85\" class=\"nounderline abstract_t\">Ishizaka A, Nakanishi M, Kasahara E, et al. Phenytoin-induced IgG2 and IgG4 deficiencies in a patient with epilepsy. Acta Paediatr 1992; 81:646.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/86\" class=\"nounderline abstract_t\">Kato Z, Watanabe M, Kondo N. IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment. Eur J Pediatr 2003; 162:209.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/87\" class=\"nounderline abstract_t\">Qvarfordt I, Riise GC, Andersson BA, Larsson S. IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations. Thorax 2001; 56:445.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/88\" class=\"nounderline abstract_t\">Sorensen RU, Leiva LE, Giangrosso PA, et al. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 1998; 17:685.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/89\" class=\"nounderline abstract_t\">Briere EC, Rubin L, Moro PL, et al. Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2014; 63:1.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/90\" class=\"nounderline abstract_t\">Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58:e44.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/91\" class=\"nounderline abstract_t\">Guti&eacute;rrez-Tarango MD, Berber A. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest 2001; 119:1742.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/92\" class=\"nounderline abstract_t\">Buckley RH. Immunoglobulin G subclass deficiency: fact or fancy? Curr Allergy Asthma Rep 2002; 2:356.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/93\" class=\"nounderline abstract_t\">Abdou NI, Greenwell CA, Mehta R, et al. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults. Int Arch Allergy Immunol 2009; 149:267.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/94\" class=\"nounderline abstract_t\">Shearer WT, Buckley RH, Engler RJ, et al. Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI). Ann Allergy Asthma Immunol 1996; 76:282.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/95\" class=\"nounderline abstract_t\">Meyts I, Bossuyt X, Proesmans M, De B. Isolated IgG3 deficiency in children: to treat or not to treat? Case presentation and review of the literature. Pediatr Allergy Immunol 2006; 17:544.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/96\" class=\"nounderline abstract_t\">Avanzini MA, Bj&ouml;rkander J, S&ouml;derstr&ouml;m R, et al. Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections. Clin Exp Immunol 1994; 96:54.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/97\" class=\"nounderline abstract_t\">Barlan IB, Geha RS, Schneider LC. Therapy for patients with recurrent infections and low serum IgG3 levels. J Allergy Clin Immunol 1993; 92:353.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/98\" class=\"nounderline abstract_t\">Olinder-Nielsen AM, Granert C, Forsberg P, et al. Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up. Scand J Infect Dis 2007; 39:44.</a></li><li><a href=\"https://www.uptodate.com/contents/igg-subclass-deficiency/abstract/99\" class=\"nounderline abstract_t\">Ortigas AP, Leiva LE, Moore C, et al. Natural history of specific antibody deficiency after IgG replacement therapy. Ann Allergy Asthma Immunol 1999; 82:71.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3906 Version 16.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H28\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H3539609208\" id=\"outline-link-H3539609208\">DEFINITIONS</a><ul><li><a href=\"#H1598063723\" id=\"outline-link-H1598063723\">Clinically significant deficiency</a></li><li><a href=\"#H1302737383\" id=\"outline-link-H1302737383\">Lower limits of normal</a></li></ul></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H99694778\" id=\"outline-link-H99694778\">PATHOGENESIS</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H6410636\" id=\"outline-link-H6410636\">Asymptomatic</a></li><li><a href=\"#H2849742500\" id=\"outline-link-H2849742500\">Symptomatic</a><ul><li><a href=\"#H2038392682\" id=\"outline-link-H2038392682\">- Associated disorders</a></li><li><a href=\"#H4139201961\" id=\"outline-link-H4139201961\">- Specific deficiencies</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">IgG1 deficiency</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">IgG2 deficiency</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">IgG3 deficiency</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">IgG4 deficiency</a></li></ul></li></ul></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">EVALUATION</a><ul><li><a href=\"#H2631432465\" id=\"outline-link-H2631432465\">Initial laboratories</a></li><li><a href=\"#H3974236503\" id=\"outline-link-H3974236503\">Referral and further evaluation</a><ul><li><a href=\"#H3248284418\" id=\"outline-link-H3248284418\">- Assess antibody function</a><ul><li><a href=\"#H263812276\" id=\"outline-link-H263812276\">Children under two years of age</a></li><li><a href=\"#H3455040458\" id=\"outline-link-H3455040458\">Response patterns seen with IgG subclass deficiency</a></li></ul></li><li><a href=\"#H146322460\" id=\"outline-link-H146322460\">- IgG subclass levels</a></li></ul></li></ul></li><li><a href=\"#H1701610\" id=\"outline-link-H1701610\">DIAGNOSIS</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">MANAGEMENT</a><ul><li><a href=\"#H21\" id=\"outline-link-H21\">Vaccination</a></li><li><a href=\"#H1918323\" id=\"outline-link-H1918323\">Treatment of infections</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Management of other sinopulmonary disease</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">Prophylactic antibiotics</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">Immune globulin therapy</a></li></ul></li><li><a href=\"#H26\" id=\"outline-link-H26\">PROGNOSIS</a></li><li><a href=\"#H27\" id=\"outline-link-H27\">MONITORING</a></li><li><a href=\"#H4256380096\" id=\"outline-link-H4256380096\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H3136827177\" id=\"outline-link-H3136827177\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ALLRG/3906|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ALLRG/58666\" class=\"graphic graphic_figure\">- Normal IgG subclass levels in infants and children</a></li></ul></li><li><div id=\"ALLRG/3906|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ALLRG/50967\" class=\"graphic graphic_table\">- Levels of IgG subclasses</a></li><li><a href=\"image.htm?imageKey=ALLRG/66552\" class=\"graphic graphic_table\">- Low IgG subclass levels in different populations</a></li><li><a href=\"image.htm?imageKey=ALLRG/110543\" class=\"graphic graphic_table\">- Properties of IgG subclasses</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">Acute bacterial rhinosinusitis in children: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-bronchitis-in-adults\" class=\"medical medical_review\">Acute bronchitis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=an-overview-of-asthma-management\" class=\"medical medical_review\">An overview of asthma management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-recurrent-infections\" class=\"medical medical_review\">Approach to the adult with recurrent infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-child-with-recurrent-infections\" class=\"medical medical_review\">Approach to the child with recurrent infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=assessing-the-immunologic-response-to-vaccination\" class=\"medical medical_review\">Assessing the immunologic response to vaccination</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ataxia-telangiectasia\" class=\"medical medical_review\">Ataxia-telangiectasia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-mucocutaneous-candidiasis\" class=\"medical medical_review\">Chronic mucocutaneous candidiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bronchiectasis-in-adults\" class=\"medical medical_review\">Clinical manifestations and diagnosis of bronchiectasis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-epidemiology-and-diagnosis-of-common-variable-immunodeficiency-in-adults\" class=\"medical medical_review\">Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=community-acquired-pneumonia-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">Community-acquired pneumonia in children: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=igg-subclasses-physical-properties-genetics-and-biologic-functions\" class=\"medical medical_review\">IgG subclasses: Physical properties, genetics, and biologic functions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immune-globulin-therapy-in-primary-immunodeficiency\" class=\"medical medical_review\">Immune globulin therapy in primary immunodeficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inherited-disorders-of-the-complement-system\" class=\"medical medical_review\">Inherited disorders of the complement system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=laboratory-evaluation-of-the-immune-system\" class=\"medical medical_review\">Laboratory evaluation of the immune system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mannose-binding-lectin-deficiency\" class=\"medical medical_review\">Mannose-binding lectin deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-intravenous-immune-globulin-ivig-therapy\" class=\"medical medical_review\">Overview of intravenous immune globulin (IVIG) therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pharmacotherapy-of-allergic-rhinitis\" class=\"medical medical_review\">Pharmacotherapy of allergic rhinitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pneumococcal-streptococcus-pneumoniae-conjugate-vaccines-in-children\" class=\"medical medical_review\">Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-haemophilus-influenzae-type-b-infection\" class=\"medical medical_review\">Prevention of Haemophilus influenzae type b infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-humoral-immunodeficiencies-an-overview\" class=\"medical medical_review\">Primary humoral immunodeficiencies: An overview</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-immunodeficiency-overview-of-management\" class=\"medical medical_review\">Primary immunodeficiency: Overview of management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pulmonary-complications-of-primary-immunodeficiencies\" class=\"medical medical_review\">Pulmonary complications of primary immunodeficiencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=secondary-immunodeficiency-due-to-underlying-disease-states-environmental-exposures-and-miscellaneous-causes\" class=\"medical medical_review\">Secondary immunodeficiency due to underlying disease states, environmental exposures, and miscellaneous causes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=selective-iga-deficiency-clinical-manifestations-pathophysiology-and-diagnosis\" class=\"medical medical_review\">Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-primary-immunodeficiencies\" class=\"medical medical_society_guidelines\">Society guideline links: Primary immunodeficiencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=subcutaneous-immunotherapy-for-allergic-disease-indications-and-efficacy\" class=\"medical medical_review\">Subcutaneous immunotherapy for allergic disease: Indications and efficacy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=transient-hypogammaglobulinemia-of-infancy\" class=\"medical medical_review\">Transient hypogammaglobulinemia of infancy</a></li></ul></div></div>","javascript":null}